4.8 Article

Galactosylated cellulosic sponge for multi-well drug safety testing

Journal

BIOMATERIALS
Volume 32, Issue 29, Pages 6982-6994

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.biomaterials.2011.05.087

Keywords

Cellulose; Galactose; Hydrogel; Sponge; Cytochrome P450; Drug induction

Funding

  1. Institute of Bioengineering and Nanotechnology, Biomedical Research Council, Agency for Science, Technology and Research (A*STAR) of Singapore
  2. Janssen Cilag [R-185-000-182-592]
  3. Singapore-MIT Alliance Computational and Systems Biology Flagship Project [C-382-641-001-091]
  4. SMART BioSyM and Mechanobiology Institute of Singapore [R-714-001-003-271]

Ask authors/readers for more resources

Hepatocyte spheroids can maintain mature differentiated functions, but collide to form bulkier structures when in extended culture. When the spheroid diameter exceeds 200 mu m, cells in the inner core experience hypoxia and limited access to nutrients and drugs. Here we report the development of a thin galactosylated cellulosic sponge to culture hepatocytes in multi-well plates as 3D spheroids, and constrain them within a macroporous scaffold network to maintain spheroid size and prevent detachment. The hydrogel-based soft sponge conjugated with galactose provided suitable mechanical and chemical cues to support rapid formation of hepatocyte spheroids with a mature hepatocyte phenotype. The spheroids tethered in the sponge showed excellent maintenance of 3D cell morphology, cell cell interaction, polarity, metabolic and transporter function and/or expression. For example, cytochrome P450 (CYP1A2, CYP2B2 and CYP3A2) activities were significantly elevated in spheroids exposed to beta-naphthoflavone, phenobarbital, or pregnenolone-16 alpha-carbonitrile, respectively. The sponge also exhibits minimal drug absorption compared to other commercially available scaffolds. As the cell seeding and culture protocols are similar to various high-throughput 2D cell-based assays, this platform is readily scalable and provides an alternative to current hepatocyte platforms used in drug safety testing applications. (C) 2011 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available